SEC Filings for AgeX Therapeutics Inc. (AGE)

$ 1.41   -0.02 (-1.40%) Volume: 41.58k 8:00 PM EST 14-Nov-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)311/14/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)3911/14/2019
8-KCurrent report pursuant to Section 13 or 15(d)410/18/2019
8-KCurrent report pursuant to Section 13 or 15(d)410/03/2019
8-KCurrent report pursuant to Section 13 or 15(d)3809/09/2019
3Initial statement of beneficial ownership of securities108/20/2019
SC 13DGeneral statement of acquisition of beneficial ownership908/16/2019
4Statement of changes in beneficial ownership of securities108/15/2019
8-KCurrent report pursuant to Section 13 or 15(d)308/14/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)10208/14/2019
8-KCurrent report pursuant to Section 13 or 15(d)408/05/2019
8-KCurrent report pursuant to Section 13 or 15(d)1105/15/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)25305/15/2019
10-K/A[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]3104/30/2019
8-KCurrent report pursuant to Section 13 or 15(d)904/01/2019
<<
First
<
Prev
12345